Medication Adherence, Complementary Medicine Usage and Progression of Diabetic Chronic Kidney Disease in Thais
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 16, 467-477
Abstract
Purpose: Non-adherence to medication is receiving more attention as a significant problem common to management of chronic diseases including diabetes and chronic kidney disease (CKD). This study was designed to assess the medication adherence and self-medication in a cohort of Thai patients with diabetic kidney disease, and its association with clinical outcomes. Patients and Methods: Non-dialysis patients with diabetic CKD visiting outpatient’s clinics of Siriraj Hospital, the largest tertiary care in Thailand, were asked for participation. Self-administered questionnaire was given to assess medication adherence (the 6-item-medication-taking-behavior measure in Thai), complementary medicine usage, and personal information. Clinical, pharmaceutical, and relevant laboratory data (at current and the last visit of around 12 months) were abstracted from the medical records. Results: Of the 220 participants eligible (54.1% male, mean age 71.3), 50.9%, 24.1%, and 25% were classified as high-, medium-, and low-medication adherence, respectively. Overall, 24.1% reported self-usage of at least one type of herbal or complementary medicines. The most commonly identified items were cordyceps, cod liver oil, Nan Fui Chao, and turmeric (6 each), with unidentified Thai herbal mixture in 11. On multivariate analysis, late-stage CKD (stage IV–V) was the only independent predictor for low adherence (odds ratio (OR), 5.54; 95% confidence interval (CI), 2.82– 10.88). Low adherence was associated with higher blood pressure, lower estimated glomerular filtrate rate (eGFR), and more eGFR decline with greater risk of being rapid CKD progressor (annual eGFR drop > 5 mL/min/1.73 m2) [OR, 1.15; 95% CI, 1.06– 1.25]. Conclusion: Medication taking behavior was a frequently encountered problem in Thai diabetic CKD patients. Increased medication non-adherence was independently predicted by stages of increasing CKD severity, and it was associated with poorer hypertensive control and kidney outcome. Targeting interventions to improve medication adherence should be an important strategy to slow CKD progression among patients with diabetic CKD.Keywords
This publication has 25 references indexed in Scilit:
- Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patientsHealth and Quality of Life Outcomes, 2016
- Medication Adherence: Truth and ConsequencesThe American Journal of the Medical Sciences, 2016
- Development and psychometric testing of the medication taking behavior tool in Thai patientsInternational Journal of Clinical Pharmacy, 2016
- Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional surveyBMC Complementary and Alternative Medicine, 2013
- Adherence to Antihypertensive Agents and Blood Pressure Control in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2010
- Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview StudyAmerican Journal of Kidney Diseases, 2010
- Herbal medicines and chronic kidney diseaseNephrology, 2010
- Psychometric Properties of the Thai Version of the 8-item Morisky Medication Adherence Scale in Patients with Type 2 DiabetesAnnals of Pharmacotherapy, 2009
- Development of an International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q)The Journal of Alternative and Complementary Medicine, 2009
- A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal diseaseBMC Nephrology, 2008